20th Annual Discovery on Target

Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.

We aim to meet your research needs. Visit numerous concurrent sessions for informative presentations, lively dialogue, and meaningful connections with peers. Customize your experience further through focused short courses, interactive discussions, and networking options that help you engage with experts and solutions providers.

Our 20th Annual event brings back popular topics like PROTACs and RNA plus new programming on immunomodulation, antivirals, neurodegeneration targets, KRAS, and AI.

Topics: PROTACs and Molecular Glues – Part 1, Target Identification and Validation – Part 1, Targeting RNA, Small Molecule Immuno-Oncology Targets, GPCR-Based Drug Discovery, Antibodies Against Membrane Protein Targets – Part 1, Targeting KRAS and Other Small G Proteins, Artificial Intelligence in Drug Discovery – Part 1, PROTACs and Molecular Glues – Part 2, Target Identification and Validation – Part 2, New Antivirals, NASH and Fibrosis, Neurodegeneration Targets, Antibodies Against Membrane Protein Targets – Part 2, Drug Lead Generation Strategies, Artificial Intelligence in Drug Discovery – Part 2,